Shambhu Aryal MD
Cystic Fibrosis, Interstitial Lung Diseases, Lung Transplantation Medicine, Pulmonary Vascular Medicine
Medical Director, Inova Lung Transplant Program and Inova WASOG Sarcoidosis Center of Excellence
Join to View Full Profile
3300 Gallows RdHeart and Lung TransplantFalls Church, VA 22042
Phone+1 703-776-2986
Fax+1 703-776-3515
Dr. Aryal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shambhu Aryal is a transplant pulmonologist in Falls Church, VA and is affiliated with Inova Fairfax Hospital. He received his medical degree from Tribhuvan University Inst of Medicine and has been in practice 12 years. He specializes in the management of Advanced Lung Diseases including Transplant Pulmonology and Sarcoidosis.
He is the medical director of the Inova Lung Transplant Program and the Inova WASOG Comprehensive Sarcoidosis Center of Excellence.
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2013 - 2014
University of Kentucky College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2012
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2006 - 2009
Tribhuvan University Inst of MedicineClass of 2005
Certifications & Licensure
VA State Medical License 2017 - 2026
NC State Medical License 2013 - 2018
KY State Medical License 2009 - 2014
DC State Medical License 2006 - 2009
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19 Start of enrollment: 2020 Jun 04
- AlloSure Lung Assessment and Metagenomics Outcomes Study Start of enrollment: 2021 Oct 29
Publications & Presentations
PubMed
- Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure.Michael B Keller, David Newman, Muhtadi Alnababteh, Ann Bon, Lucia Ponor
The Journal of Heart and Lung Transplantation. 2025-03-20 - Review of the Diagnosis and Management of Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH).Zein Kattih, Ho Cheol Kim, Shambhu Aryal, Steven D Nathan
Journal of Clinical Medicine. 2025-03-17 - Serial Pulmonary Hemodynamics in Patients with IPF Listed for Lung Transplant.Steven D Nathan, Ho Cheol Kim, Christopher S King, Shambhu Aryal, Christopher Thomas
American Journal of Respiratory and Critical Care Medicine. 2025-02-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
